Objective. We sought to determine whether novel approaches to volumetric assessment of the early placenta can yield significant predictors of adverse outcome. Methods. We measured placental volume (PV) at 11 to 14 weeks using virtual organ computer-aided analysis and normalized the PV to the crown-rump length (CRL) to yield the placental quotient (PQ = PV/CRL). We also calculated the mean placental diameter (MPD) from 4 measurements taken at 45° intervals to serve as a surrogate for the fetal-maternal surface area. On the fetal side, the distance from the cord insertion (CI) to the placental margin was measured every 45°. Mean cord distance (MCD) is proposed as a novel descriptor of the chorionic plate and CI. Sonographic variables were analyzed as predictors of a composite adverse pregnancy outcome (COMP = small for gestational age [SGA], preeclampsia, spontaneous preterm birth, or neonatal intensive care unit admission). Results. A total of 135 patients were included, and 40 (29.6%) had an adverse outcome. The mean PQ (P = .02) and MCD (P = .02) were significantly lower in patients with COMP, although MPD was not significantly different (P = .26). A PQ of less than 1.00 (relative risk [RR], 2.3 [95% confidence interval, 1.4-2.7]) and an MCD of less than 4.00 cm (RR, 1.8 [1.1-2.9]) conferred an increased risk for COMP. Prediction models adjusting for parity and race yielded favorable characteristics [PV: area under the curve [AUC], 0.796; P = .04; PQ: AUC, 0.802; P = .03; MCD: AUC, 0.800; P = .04; and MPD: AUC, 0.782; P = .07). Secondary models targeting SGA as the sole outcome also showed excellent prediction (PV: AUC, 0.820; PQ: AUC, 0.810; MCD: AUC, 0.827; and MPD: AUC, 0.795). Conclusions. In addition to volume, 3-dimensional sonography allows for novel techniques to measure other aspects of gross placental morphologic characteristics and CI, which can yield promising biologically plausible early predictors of fetal growth and adverse perinatal outcome.
Advances in sonography have allowed for 3-dimensional (3D) assessment of in utero structures. Such technology has been applied to the placenta and has focused mostly on placental volume (PV) as a possible predictor of adverse pregnancy outcome. Indeed, several studies have shown a significant association between PV in early pregnancy and adverse pregnancy outcome. [1] [2] [3] [4] Nevertheless, the test characteristics remain suboptimal for clinical use because of their limited positive predictive value.
Research to date has focused primarily on PV as a possible indicator of placental growth and function. However, several descriptors of gross placental morphologic characteristics other than PV are independently associated with fetal growth. [5] [6] [7] For example, it is not clear whether placental disk diameter and disk thickness make equivalent contributions to fetal growth. In fact, chorionic disk diameter and disk thickness have different patterns of relationships to fetal growth in male versus female infants, the importance of which is not yet known. 8 In addition, recent evidence points to the importance of the location of the umbilical cord insertion (CI) onto the chorionic disk. Eccentric CI is associated with sparse chorionic vascular distribution and decreased transport efficiency. Therefore, for a given placental weight, a placenta with an eccentric CI yields a smaller birth weight than a centrally inserted cord. 9 These observations are biologically plausible because the greater the lateral dimensions of the chorionic plate, the greater the surface area of the maternal-fetal interface available for the exchange of nutrients. Similarly, an eccentric CI likely represents an asymmetric villous vascular network, which adversely affects the efficiency of nutrient exchange. Thus, it may be that novel sonographic measures of the maternal-fetal surface area and the umbilical CI may improve the performance of early placental sonography as a screening test for adverse outcomes. We sought to use 3D sonographic technology to develop novel approaches to evaluate the early placenta and test their utility in predicting adverse pregnancy outcomes.
Materials and Methods
We conducted a prospective cohort study at the obstetric and gynecologic ultrasound unit of the New York University Medical Center. This study protocol was approved by the Institutional Review Board, and written informed consent was obtained from all study participants. Women were recruited on presentation at 11 to 14 weeks' gestation during routine aneuploidy screening. During the nuchal translucency examination, the transabdominal probe (Voluson E8; GE Healthcare, Milwaukee, WI) was used to obtain a 3D volume sweep of the placenta. The volumes were obtained using power Doppler imaging (quality, maximum; pulse repetition frequency, 0.6 kHz; and gain adjusted to just below the snow artifact) with the sweep angle opened to ensure inclusion of the entire placenta. The volume was reacquired if an obvious fetal motion artifact occurred during the sweep or if it appeared that a substantial portion of the placenta was excluded from the sweep. Volumes were stored for offline analysis postpartum. The pregnancy was allowed to continue per the routine of the clinical provider.
The PV sets were then manipulated using 4D View software (GE Healthcare, Kretztechnik, Zipf, Austria). Because the placental measurements were analyzed after the conclusion of the pregnancy, there was no possibility that the results could affect clinical care. In addition, each volume was manipulated by a single investigator (N.S.), who was not involved in the collection of pregnancy outcome data. This served to minimize any potential bias in the measurement techniques.
Each volume was manipulated using the following 4 techniques aimed to obtain 7 sonographic variables to be tested as potential predictors of adverse pregnancy outcomes:
1. The PV was isolated using virtual organ computer-aided analysis, which involves manually tracing the perimeter of the placenta in successive images that are obtained by automatic rotation of the image around the y-axis in 30°i ntervals until the image completes a 180° flip around the y-axis. With these traced perimeters, the software reconstructs the shape and volume of the object (Figure 1 ). The color signal in the stored volume was turned off, and the measurements were performed with only gray scale voxels apparent to ensure that the placental borders were not obscured by the vascular signal. This volume was then normalized to gestational age by dividing it by the crown-rump length (CRL) to obtain the placental quotient (PQ = PV/CRL).
2.
In an effort to quantify the surface area at the maternal-fetal interface, we adapted the rotational measurement technique to obtain a mean placental diameter (MPD) as measured at the uterine-placental border. We propose that this approach is superior to a simple placental diameter obtained from a 2-dimensional view because the placenta is an irregular shape, and a single diameter may not accurately reflect the lateral placental dimensions. In addition, without a multiplanar 3D view, one cannot ensure that the diameter measurement is being taken through the center of the placenta. A rotational 3D approach, however, allows for a standardized method to obtain several equally spaced diameter measurements that would account for the irregularity of the placental shape. In addition, the placenta can be accurately centered in the 3 orthogonal sectional planes (A, B, and C). After centering the placenta in the 3 planes, the uterine-placental interface (ie, the maternal side of the placenta) was manually traced and measured in planes A and B, yielding 2 orthogonal diameter measurements at a right angle to each other because these planes are orthogonal to each other around the y-axis. The volume was then rotated 45° around the y-axis, and the uterineplacental interface was remeasured in planes A and B. As a result of these manipulations, we obtained 4 measurements of the placental diameter equally spaced at 45° intervals around the circumference of the placenta (Figure 2 ).
The mean of these values, MPD, is proposed as a descriptive variable reflecting the extent of the uterine-placental surface area. In addition, we used the MPD to derive a placental morphology index (PMI = MPD/PQ). This variable is intended to help describe the relative contribution of the lateral placental dimensions to the overall PV. Thus, for a given PQ, a high PMI indicates a placenta that is relatively wider and flatter compared to one with a low PMI.
3. We then scrolled through each PV to find and measure the maximum placental thickness (MaxThick). Attempting to measure thickness using 2-dimensional imaging carries the risk of obtaining a false measurement because of oblique imaging of the placenta. However, with the sectional plane view of the 3D volume set, plane B can be used to ensure that the thickness measurement is not a tangential measurement that is falsely increased.
4. Finally, we focused on the fetal surface of the placenta and used an adapted rotational technique to assess the marginality of the umbilical CI and its relationship with the overall size of the chorionic plate. The color mode was turned back on so that the color voxels, representing vascularity, were visible. The CI was identified by scrolling through the volume and using the power Doppler signal to locate the point of insertion. The placenta was positioned with the CI at the center, so that subsequent rotations would pivot around the CI. The distance from the CI to the placental margin was traced and measured in both directions and in both the A and B planes. The volume was then rotated 45° around the y-axis, and the measurements were repeated. This technique yields 8 measurements of the distance from the umbilical CI to the nearest placental edge at 45°i ntervals around the placental circumference ( Figure 3 ). The mean of these values, mean cord distance (MCD), is intended to serve as a novel descriptor of the chorionic plate and the centricity of the CI. The smallest of the 8 values, or minimum cord distance (MinCD), represents the shortest distance from the CI to the placental edge.
Demographic data, such as maternal age, parity, race, and body mass index (BMI), as well as pregnancy outcome data, including gestational age at delivery, birth weight, and pregnancy complications, were collected from the hospital medical records associated with the delivery hospitalization. Gestational age was based on firsttrimester sonographic dating if a definite last menstrual period was not available or if there was a greater than 7-day discrepancy between menstrual dating and first-trimester sonographic biometric measurements. Preeclampsia was defined as the finding of a systolic blood pressure of 140 mm Hg or higher or a diastolic blood pressure of 90 mm Hg or higher on 2 occasions 6 hours apart in the presence of substantial proteinuria, defined as a 24-hour urine collection containing greater than 300 mg of protein or a urine dipstick with a 1+ protein value or higher. Birth weight percentiles were determined on the basis of the curve of Alexander et al. 10 Small for gestational age (SGA) was defined as a birth weight at or below the 10th percentile for the completed gestational week.
A composite adverse pregnancy outcome (COMP) was defined as pregnancies that resulted in any of the following: SGA, PEC, spontaneous preterm birth before 37 weeks, and admission to the neonatal intensive care unit (NICU). The analyses were also performed using SGA as the primary outcome given the known association between placental size at term and birth weight.
Univariate analyses were used to determine whether maternal age, race, parity, and pregravid BMI were associated with an adverse outcome in our cohort. Maternal age and BMI were analyzed as continuous variables. Parity was analyzed as dichotomous variable (nulliparous, parous). The Student t test was used for continuous variables, and χ 2 and Fisher exact tests were used for categorical variables. Those variables found to be significant were then included in subsequent multivariate analyses.
Mean values of each sonographic variable were compared between those with normal outcomes and those with COMP. For those sonographic variables that were significantly associated with COMP, unadjusted receiver operating characteristic (ROC) curves were used to identify the optimal cut point. Relative risks (RRs), sensitivity, specificity, and predictive values were then calculated for the unadjusted variable.
Logistic regression was then used to test each sonographic variable as an independent predictor of COMP while adjusting for the significant demographic variables. To be able to better compare the effect size for each sonographic variable, the models were also run after standardizing each variable by the following formula: standardized value = (individual valuemean value)/SD. This approach allows for comparison of the adjusted odds ratios independent of the unit of the variable. For those sonographic variables that remained significant after multivariate analysis, the models were plotted as ROC curves, and the area under the curve (AUC) for each model was noted as a measure of the performance of that model. Tests of equality were used to compare the AUC values for the different ROC curves. Similar statistical analyses were performed using SGA as the outcome of interest. P < .05 was considered statistically significant. All above analyses were performed using StataIC version 10.1 software (StataCorp, College Station, TX).
Results
Of 221 women enrolled, 135 had complete sonographic and pregnancy outcome data available for analysis after 46 women were excluded for delivering at outside institutions and 40 were missing the sonographic volumes or had substantial artifacts on their volumes precluding a complete set of sonographic data. The demographic information can be seen in Table 1 . Nulliparity and Hispanic race were found to be associated with adverse pregnancy outcomes in this cohort. Overall, 40 patients (29.6%) had a COMP, and 23 (17%) delivered an SGA neonate ( Table 2) .
As expected, PV did increase significantly with advancing gestational age within the 11-to 14-week gestational age window ( Figure 4A ). However, dividing the PV by the CRL to obtain the PQ effectively normalized the volume measurement to gestational age and limited the variability across this gestational age window ( Figure  4B ). Also, MPD and MCD increased only minimally with advancing gestational age from 11 to 14 weeks (Figure 4, C and D) .
The mean sonographic placental measurements for those women who had an adverse outcome and those whose pregnancy was uneventful are presented in Table 3 . There was a significantly lower mean PQ and MCD and a significantly higher mean PMI with both COMP as well as SGA. In addition, a significantly smaller mean PV was seen in those pregnancies that resulted in an SGA neonate. The mean values for MPD, MaxThick, and MinCD were not significantly different in those pregnancies with COMP or SGA compared to those with normal pregnancy outcomes. The unadjusted ROC curves for those sonographic variables with significant associations with either COMP or SGA can be seen in Figure 5 . After choosing optimal cut points, test characteristics of each of these sonographic variables as predictors of adverse outcomes were calculated (Table 4) .
Because race and parity were noted to be significantly associated with COMP, multivariate analyses were performed adjusting for these 2 covariates. The PV, PQ, PMI, and MCD were all found to have significant independent associations with both COMP and SGA. In addition, adjustment for race and parity revealed a trend toward a significant association between the MPD and both COMP and SGA. Overall, the model using PMI (AUC, 0.813) was most predictive of COMP, followed closely by MCD (AUC, 0.806) and PQ (AUC, 0.802). The PMI (AUC, 0.828) and MCD (AUC, 0.827) models were also the most predictive for SGA as the outcome of interest, although the PV (AUC, 0.820) and PQ (AUC, 0.810) models also performed well (Table 5) . Overall, there were no significant differences among the 4 statistically significant models for prediction of either a COMP (P = .8) or SGA (P = .3; Figure 6 ).
Discussion
Because the pathophysiologic basis for many obstetric complications is believed to emanate from impaired trophoblastic invasion and devel- 
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In fact, several authors have shown significant associations between early PV and clinical pregnancy outcomes. For example, Hafner et al 12 found that first-trimester PV had similar sensitivity for detecting PEC and fetal growth restriction as second-trimester uterine artery Doppler measurement, but with the advantage of being performed earlier in gestation. The same group of investigators showed that women destined to develop PEC with or without fetal growth restriction had different rates of volumetric placental growth compared to controls. 4 More recently, Rizzo et al 2 found that early PV at 11 to 14 weeks detected 56% of PEC cases and 67% of PEC cases requiring delivery before 32 weeks. Furthermore, when combined with uterine artery Doppler measurement, they detected 83% of severe PEC cases requiring early delivery. However, a notable limi-
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J Ultrasound Med 2010; 29:1203-1212 A B C D tation in the above findings is the poor predictive value associated with the use of PV as a screening test. For example, to achieve the 83% sensitivity for early severe PEC, Rizzo et al 2 reported an 18% positive predictive value. Our study confirmed the suboptimal test performance of early PV as a predictor of adverse outcomes. On the basis of the pathology literature, which has shown that variations in placental shape and umbilical cord location affect placental function independent of placental weight, 6,7,9 we attempted to target other biologically plausible aspects of gross placental morphologic characteristics as predictors of adverse pregnancy outcomes. For example, it would be intuitive that an increased surface area at the maternal-fetal interface would lead to enhanced nutrient and gas exchange and consequently to more favorable outcomes. To our knowledge, no other sonographic techniques have been reported that attempt to capture this parameter.
Three-Dimensional Placental Measurements in Early Pregnancy
In this study, we developed a method to obtain several placental diameters in a standardized manner. The use of sectional planes allows the user to ensure that the placenta is positioned horizontally to avoid tangential measurements and that the axis of rotation is at the center of the placenta. Consistent with the expected lateral placental growth, the MPD increased from 11 to 14 weeks ( Figure 4C ). However, while a trend toward significance was noted, this value failed to reach statistical significance in the adjusted models and did not perform well as a predictor of adverse outcomes. We also calculated a placental area based on the equation for the area of a circle using the MPD as the diameter of the circle, as well as the equation for an ellipse using the largest and smallest placental diameters as the long and short axes, but neither improved the testing performance (data not shown). It remains to be seen whether the poor performance of the MPD is related to the gestational age when we acquired it or whether, despite the biological plausibility, small differences in the maternalfetal surface area do not appreciably affect placental function. Another interesting finding is the relationship between the placental surface area and PV, defined by us as the PMI. This parameter was associated with a higher RR for adverse outcomes than the MPD or PQ alone and performed better in the adjusted models as well. In addition, the AUC for the multivariate model using the PMI was also higher than that for a model using both the MPD and PQ as separate variables (COMP, 7.997; SGA, 0.812). Thus, it seems that a high surface area to volume ratio is associated with an increased risk of an adverse outcome. In other words, it would seem that if one takes two placentas of equal volumes, but one is flatter and spread over a wider surface area and the other is narrower but thicker, the wide and flat placenta would be more likely to result in an adverse pregnancy outcome.
Thus, despite the inability of a single measure of MaxThick to predict outcome, the significant associations of the PQ and PMI with outcome, coupled with the lack of a significant association between the MPD and outcome, support the notion that defects in early placental growth that lead to adverse pregnancy outcomes affect early sprouting of the villi (which contributes to placental thickness) rather than an inability for the placenta to laterally expand due to a hostile maternal environment (ie, trophotropism). In fact, different maternal and pregnancy-related complications are known to yield altered patterns of villous capillary branching. 15 Our findings appear to support the notion that these changes in villous developments and branching are already taking place in the first trimester, long before clinical sequelae are evident. Histologic correlation may prove helpful in supporting this interpretation of these data. On the other hand, our results show that small variations in the surface area of the maternal-fetal interface do not appear to play a major role in future placental function. This is in contrast to lateral placental growth at term, which has been shown to correlate with fetal growth. 5, 6 It may be that differences in the timing of the insult to placental growth may manifest differently. Thus, the importance of variations in lateral placental growth seen at term may represent later deficiencies in placental development, whereas earlier dysfunction may not affect lateral growth as much.
Regarding the umbilical CI site, the lack of a significant association between the MinCD and adverse outcomes supports current clinical practice to manage pregnancies with a marginal CI similarly to other routine pregnancies. However, the fact remains that eccentric cords are associated with poor fetal growth. Thus, we developed the MCD variable, which takes into account the chorionic diameter as well as the overall position on the chorionic plate. For example, two placentas with the same chorionic diameter will have MCDs that vary by cord location. The more central cord would lead to a higher MCD. Because pathologic data have shown that a central cord leads to more efficient chorionic circulation, a greater MCD would be expected to be associated with improved placental efficiency and function. Indeed, we found an independent association between a higher MCD and the absence of adverse outcomes.
Our study was limited by the small size of the cohort, which limited our ability to stratify our analyses. However, the relatively broad definition of our COMP yielded a nearly 30% rate of adverse outcomes. Much of this was driven by SGA, which does not differentiate a constitutionally small neonate from a truly growth-restricted one. This is an important point because it is the latter neonate who is at risk for morbidity. However, because this pilot study was investigating markers of placental function, we believe that SGA is still an appropriate outcome because it remains substantially tied to placental function and efficiency. Furthermore, NICU admission was a significant contributor to a COMP, with 10% of neonates being admitted to the NICU. This was somewhat surprising given that the mean gestational age at birth was 39 weeks. Because this study was performed at a single institution, a single set of criteria was likely used in deciding which neonates were admitted to the NICU; however, it may be that NICU admission is a suboptimal surrogate for adverse outcomes because it is likely that some of these neonates were admitted as a precaution to rule out sepsis and not for neonatal distress. A larger study would likely be needed to use less prevalent surrogate outcomes, such as Apgar scores and umbilical artery acidosis. In fact, because the planned secondary analyses using SGA alone as the outcome showed similar if not more robust 
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findings, it is possible that a larger study using such outcomes would find an even stronger association between early placental measurements and pregnancy outcomes. A substantial number of women had their nuchal translucency screening in our ultrasound unit but then delivered at an outside institution. In addition, because the volumes were obtained with power Doppler imaging, they were especially sensitive to fetal motion artifacts, leading to exclusion of many other patients. Although the study protocol allowed for volumes to be reacquired if an obvious artifact was apparent, it is sometimes difficult to assess the extent of such artifacts without scrolling through the volume. Although these logistic limitations led to a smaller cohort, it is important to note that obstetric management was not altered on the basis of the volume quality, and the outcome data were collected by a different individual, who had no knowledge of whether the volume was adequate for analysis. Therefore, we have no reason to believe that the exclusion of these patients led to any selection bias.
Although the adjusted models for some of our novel sonographic variables may have performed minimally better than the PV, they remain suboptimal for clinical use, and no single variable stood out as significantly better than the others. Nonetheless, this study describes how novel approaches to sonographic volume manipulation can be used to measure early placental morphologic characteristics and develop novel placental measurements that target various aspects of the gross placenta. Such techniques may help our understanding of normal and abnormal early placental development. In addition, it may prove to be that targeted placental measurements can be used in combination with other known predictors of outcome to achieve a clinically useful screening approach. Further efforts should focus on refining these techniques and determining the optimal strategy that will yield a clinically relevant assessment of the placenta.
